Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice

Andres J. Lopez-Contreras, Julia Specks, Jacqueline Barlow, Chiara Ambrogio, Claus Desler, Svante Vikingsson, Sara Rodrigo-Perez, Henrik Green, Lene Juel Rasmussen, Matilde Murga, André Nussenzweig, Oscar Fernandez-Capetillo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

In Saccharomyces cerevisiae, absence of the checkpoint kinase Mec1 (ATR) is viable upon mutations that increase the activity of the ribonucleotide reductase (RNR) complex. Whether this pathway is conserved in mammals remains unknown. Here we show that cells from mice carrying extra alleles of the RNR regulatory subunit RRM2 (Rrm2TG) present supraphysiological RNR activity and reduced chromosomal breakage at fragile sites. Moreover, increased Rrm2 gene dosage significantly extends the life span of ATR mutant mice. Our study reveals the first genetic condition in mammals that reduces fragile site expression and alleviates the severity of a progeroid disease by increasing RNR activity.

Original languageEnglish (US)
Pages (from-to)690-695
Number of pages6
JournalGenes and Development
Volume29
Issue number7
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Ribonucleotide Reductases
Gene Dosage
Mammals
Chromosome Breakage
Saccharomyces cerevisiae
Phosphotransferases
Alleles
Mutation

Keywords

  • ATR
  • Fragile site
  • Mouse models
  • Replication stress
  • RNR

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Lopez-Contreras, A. J., Specks, J., Barlow, J., Ambrogio, C., Desler, C., Vikingsson, S., ... Fernandez-Capetillo, O. (2015). Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. Genes and Development, 29(7), 690-695. https://doi.org/10.1101/gad.256958.114

Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. / Lopez-Contreras, Andres J.; Specks, Julia; Barlow, Jacqueline; Ambrogio, Chiara; Desler, Claus; Vikingsson, Svante; Rodrigo-Perez, Sara; Green, Henrik; Rasmussen, Lene Juel; Murga, Matilde; Nussenzweig, André; Fernandez-Capetillo, Oscar.

In: Genes and Development, Vol. 29, No. 7, 01.01.2015, p. 690-695.

Research output: Contribution to journalArticle

Lopez-Contreras, AJ, Specks, J, Barlow, J, Ambrogio, C, Desler, C, Vikingsson, S, Rodrigo-Perez, S, Green, H, Rasmussen, LJ, Murga, M, Nussenzweig, A & Fernandez-Capetillo, O 2015, 'Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice', Genes and Development, vol. 29, no. 7, pp. 690-695. https://doi.org/10.1101/gad.256958.114
Lopez-Contreras, Andres J. ; Specks, Julia ; Barlow, Jacqueline ; Ambrogio, Chiara ; Desler, Claus ; Vikingsson, Svante ; Rodrigo-Perez, Sara ; Green, Henrik ; Rasmussen, Lene Juel ; Murga, Matilde ; Nussenzweig, André ; Fernandez-Capetillo, Oscar. / Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. In: Genes and Development. 2015 ; Vol. 29, No. 7. pp. 690-695.
@article{9798ecd1b6614aa18e8ab5c460102f83,
title = "Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice",
abstract = "In Saccharomyces cerevisiae, absence of the checkpoint kinase Mec1 (ATR) is viable upon mutations that increase the activity of the ribonucleotide reductase (RNR) complex. Whether this pathway is conserved in mammals remains unknown. Here we show that cells from mice carrying extra alleles of the RNR regulatory subunit RRM2 (Rrm2TG) present supraphysiological RNR activity and reduced chromosomal breakage at fragile sites. Moreover, increased Rrm2 gene dosage significantly extends the life span of ATR mutant mice. Our study reveals the first genetic condition in mammals that reduces fragile site expression and alleviates the severity of a progeroid disease by increasing RNR activity.",
keywords = "ATR, Fragile site, Mouse models, Replication stress, RNR",
author = "Lopez-Contreras, {Andres J.} and Julia Specks and Jacqueline Barlow and Chiara Ambrogio and Claus Desler and Svante Vikingsson and Sara Rodrigo-Perez and Henrik Green and Rasmussen, {Lene Juel} and Matilde Murga and Andr{\'e} Nussenzweig and Oscar Fernandez-Capetillo",
year = "2015",
month = "1",
day = "1",
doi = "10.1101/gad.256958.114",
language = "English (US)",
volume = "29",
pages = "690--695",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "7",

}

TY - JOUR

T1 - Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice

AU - Lopez-Contreras, Andres J.

AU - Specks, Julia

AU - Barlow, Jacqueline

AU - Ambrogio, Chiara

AU - Desler, Claus

AU - Vikingsson, Svante

AU - Rodrigo-Perez, Sara

AU - Green, Henrik

AU - Rasmussen, Lene Juel

AU - Murga, Matilde

AU - Nussenzweig, André

AU - Fernandez-Capetillo, Oscar

PY - 2015/1/1

Y1 - 2015/1/1

N2 - In Saccharomyces cerevisiae, absence of the checkpoint kinase Mec1 (ATR) is viable upon mutations that increase the activity of the ribonucleotide reductase (RNR) complex. Whether this pathway is conserved in mammals remains unknown. Here we show that cells from mice carrying extra alleles of the RNR regulatory subunit RRM2 (Rrm2TG) present supraphysiological RNR activity and reduced chromosomal breakage at fragile sites. Moreover, increased Rrm2 gene dosage significantly extends the life span of ATR mutant mice. Our study reveals the first genetic condition in mammals that reduces fragile site expression and alleviates the severity of a progeroid disease by increasing RNR activity.

AB - In Saccharomyces cerevisiae, absence of the checkpoint kinase Mec1 (ATR) is viable upon mutations that increase the activity of the ribonucleotide reductase (RNR) complex. Whether this pathway is conserved in mammals remains unknown. Here we show that cells from mice carrying extra alleles of the RNR regulatory subunit RRM2 (Rrm2TG) present supraphysiological RNR activity and reduced chromosomal breakage at fragile sites. Moreover, increased Rrm2 gene dosage significantly extends the life span of ATR mutant mice. Our study reveals the first genetic condition in mammals that reduces fragile site expression and alleviates the severity of a progeroid disease by increasing RNR activity.

KW - ATR

KW - Fragile site

KW - Mouse models

KW - Replication stress

KW - RNR

UR - http://www.scopus.com/inward/record.url?scp=84926320705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926320705&partnerID=8YFLogxK

U2 - 10.1101/gad.256958.114

DO - 10.1101/gad.256958.114

M3 - Article

C2 - 25838540

AN - SCOPUS:84926320705

VL - 29

SP - 690

EP - 695

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 7

ER -